BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ferrarese A, Germani G, Gambato M, Russo FP, Senzolo M, Zanetto A, Shalaby S, Cillo U, Zanus G, Angeli P, Burra P. Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study. World J Gastroenterol 2018; 24(38): 4403-4411 [PMID: 30344424 DOI: 10.3748/wjg.v24.i38.4403]
URL: https://www.wjgnet.com/1948-5182/full/v24/i38/4403.htm
Number Citing Articles
1
Francesco Negro. Natural History of Hepatic and Extrahepatic Hepatitis C Virus Diseases and Impact of Interferon-Free HCV TherapyCold Spring Harbor Perspectives in Medicine 2020; 10(4): a036921 doi: 10.1101/cshperspect.a036921
2
Edna STRAUSS. CHRONIC HEPATITIS C IS STILL A PROBLEM FOR THE PUBLIC HEALTH CARE SYSTEM IN BRAZILArquivos de Gastroenterologia 2018; 55(4): 321 doi: 10.1590/s0004-2803.201800000-90
3
William M. Kamp, Cortlandt M. Sellers, Stacey Stein, Joseph K. Lim, Hyun S. Kim. Impact of Direct Acting Antivirals on Survival in Patients with Chronic Hepatitis C and Hepatocellular CarcinomaScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-53051-2
4
Sara Battistella, Marco Grasso, Elisa Catanzaro, Francesca D’Arcangelo, Giorgia Corrà, Giacomo Germani, Marco Senzolo, Alberto Zanetto, Alberto Ferrarese, Martina Gambato, Patrizia Burra, Francesco Paolo Russo. Evolution of Liver Transplantation Indications: Expanding HorizonsMedicina 2024; 60(3): 412 doi: 10.3390/medicina60030412
5
William M. Kamp, Cortlandt M. Sellers, Stacey Stein, Joseph K. Lim, Hyun S. Kim. Direct-Acting Antivirals Improve Overall Survival in Interventional Oncology Patients with Hepatitis C and Hepatocellular CarcinomaJournal of Vascular and Interventional Radiology 2020; 31(6): 953 doi: 10.1016/j.jvir.2019.12.809
6
Elena Campello, Claudia M. Radu, Alberto Zanetto, Cristiana Bulato, Sarah Shalaby, Luca Spiezia, Enrica Franceschet, Patrizia Burra, Francesco P. Russo, Paolo Simioni. Changes in plasma circulating microvesicles in patients with HCV‐related cirrhosis after treatment with direct‐acting antiviralsLiver International 2020; 40(4): 913 doi: 10.1111/liv.14234
7
Martina Gambato, Alberto Ferrarese. Textbook of Liver Transplantation2022; : 19 doi: 10.1007/978-3-030-82930-8_2
8
Giuseppe Losurdo, Andrea Iannone, Antonella Contaldo, Michele Barone, Enzo Ierardi, Alfredo Di Leo, Mariabeatrice Principi. Trends of Liver Stiffness in Inflammatory Bowel Disease with Chronic Hepatitis CDiagnostics 2020; 10(12): 1037 doi: 10.3390/diagnostics10121037
9
Ying Yang, Feng-Ping Wu, Wen-Jun Wang, Juan-Juan Shi, Ya-Ping Li, Xin Zhang, Shuang-Suo Dang. Real life efficacy and safety of direct-acting antiviral therapy for treatment of patients infected with hepatitis C virus genotypes 1, 2 and 3 in northwest ChinaWorld Journal of Gastroenterology 2019; 25(44): 6551-6560 doi: 10.3748/wjg.v25.i44.6551
10
Giuseppina Brancaccio, Alessandro Vitale, Giuseppe Signoriello, Giovanni B. Gaeta, Umberto Cillo. Changing indications for liver transplant: slow decline of hepatitis viruses in ItalyInfectious Diseases 2020; 52(8): 557 doi: 10.1080/23744235.2020.1763453
11
Audrey Coilly, Carine Jasseron, Camille Legeai, Filomena Conti, Christophe Duvoux, Nassim Kamar, Sébastien Dharancy, Corinne Antoine. Impact of direct antiviral agents for hepatitis C virus -induced liver diseases on registration, waiting list and liver transplant activity in FranceClinics and Research in Hepatology and Gastroenterology 2023; 47(8): 102168 doi: 10.1016/j.clinre.2023.102168
12
Stella Compagnoni, Erica Maria Bruno, Giorgio Madonia, Marco Cannizzaro, Salvatore Madonia. Direct antiviral agents in hepatitis C virus related liver disease: Don’t count the chickens before they’re hatchedWorld Journal of Gastroenterology 2021; 27(21): 2771-2783 doi: 10.3748/wjg.v27.i21.2771
13
Yuki Mori, Shuya Matsuda, Mitsuaki Sato, Masaru Muraoka, Yuichiro Suzuki, Akihisa Tatsumi, Yasuhiro Nakayama, Taisuke Inoue, Shinya Maekawa, Nobuyuki Enomoto. The Impact of Antiviral Therapy for Hepatitis C Virus on the Survival of Patients after Hepatocellular Carcinoma TreatmentInternal Medicine 2022; 61(18): 2721 doi: 10.2169/internalmedicine.8456-21
14
Egle Ciupkeviciene, Janina Petkeviciene, Jolanta Sumskiene, Gediminas Dragunas, Saulius Dabravalskis, Edita Kreivenaite, Tadas Telksnys, Gediminas Urbonas, Limas Kupcinskas. Hepatitis C Virus Epidemiology in Lithuania: Situation before Introduction of the National Screening ProgrammeViruses 2022; 14(6): 1192 doi: 10.3390/v14061192
15
G Ireland, R Simmons, M Hickman, M Ramsay, C Sabin, S Mandal. Monitoring liver transplant rates in persons diagnosed with hepatitis C: a data linkage study, England 2008 to 2017 Eurosurveillance 2019; 24(41) doi: 10.2807/1560-7917.ES.2019.24.41.1900176
16
Wei-Chen Lin, Yang-Sheng Lin, Chen-Wang Chang, Ching-Wei Chang, Tsang-En Wang, Horng-Yuan Wang, Ming-Jen Chen, Chen-Hua Liu. Impact of direct-acting antiviral therapy for hepatitis C–related hepatocellular carcinomaPLOS ONE 2020; 15(5): e0233212 doi: 10.1371/journal.pone.0233212
17
Patrizia Burra, Debora Bizzaro, Anna Gonta, Sarah Shalaby, Martina Gambato, Maria Cristina Morelli, Silvia Trapani, Annarosa Floreani, Fabio Marra, Maurizia Rossana Brunetto, Gloria Taliani, Erica Villa. Clinical impact of sexual dimorphism in non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic steatohepatitis (NASH)Liver International 2021; 41(8): 1713 doi: 10.1111/liv.14943
18
Renata Senkerikova, Sona Frankova, Milan Jirsa, Miluse Kreidlova, Dusan Merta, Magdalena Neroldova, Klara Chmelova, Julius Spicak, Jan Sperl, Pavel Strnad. PNPLA3 rs738409 G allele carriers with genotype 1b HCV cirrhosis have lower viral load but develop liver failure at younger agePLOS ONE 2019; 14(9): e0222609 doi: 10.1371/journal.pone.0222609
19
Alberto Ferrarese, Sara Battistella, Giacomo Germani, Francesco Paolo Russo, Marco Senzolo, Martina Gambato, Alessandro Vitale, Umberto Cillo, Patrizia Burra. Nash Up, Virus Down: How the Waiting List Is Changing for Liver Transplantation: A Single Center Experience from ItalyMedicina 2022; 58(2): 290 doi: 10.3390/medicina58020290
20
Jonathan Li, Vivian Wu, Calvin Q. Pan. Direct antiviral therapy for hepatitis C cirrhotic patients in liver transplantation settings: a systematic reviewHepatology International 2022; 16(5): 1020 doi: 10.1007/s12072-022-10380-1
21
Maheeba Abdulla, Aysha Mohamed Al Ghareeb, Hamed Ali Hasan Yusuf Husain, Nafeesa Mohammed, Jehad Al Qamish. Effectiveness and safety of generic and brand direct acting antivirals for treatment of chronic hepatitis CWorld Journal of Clinical Cases 2022; 10(34): 12566-12577 doi: 10.12998/wjcc.v10.i34.12566
22
Vijay Gayam, Arshpal Gill, Pavani Garlapati, Smruti Mohanty. Hepatitis B and C2020;  doi: 10.5772/intechopen.83609
23
Pierluigi Toniutto, Sarah Shalaby, Laura Mameli, Filomena Morisco, Martina Gambato, Valentina Cossiga, Maria Guarino, Fabio Marra, Maurizia R. Brunetto, Patrizia Burra, Erica Villa. Role of sex in liver tumor occurrence and clinical outcomes: a comprehensive reviewHepatology 2023;  doi: 10.1097/HEP.0000000000000277
24
Francesco Paolo Russo, Alberto Zanetto, Elisa Pinto, Sara Battistella, Barbara Penzo, Patrizia Burra, Fabio Farinati. Hepatocellular Carcinoma in Chronic Viral Hepatitis: Where Do We Stand?International Journal of Molecular Sciences 2022; 23(1): 500 doi: 10.3390/ijms23010500
25
Hugo Perazzo, Rodolfo Castro, Paula M Luz, Mariana Banholi, Rafaela V Goldenzon, Sandra W Cardoso, Beatriz Grinsztejn, Valdilea G Veloso. Effectiveness of generic direct-acting agents for the treatment of hepatitis C: systematic review and meta-analysisBulletin of the World Health Organization 2020; 98(3): 188 doi: 10.2471/BLT.19.231522
26
Giacomo Germani, Alberto Ferrarese, Francesca D’Arcangelo, Francesco Paolo Russo, Marco Senzolo, Martina Gambato, Alberto Zanetto, Umberto Cillo, Paolo Feltracco, Paolo Persona, Eugenio Serra, Giuseppe Feltrin, Giovanni Carretta, Alfio Capizzi, Daniele Donato, Michele Tessarin, Patrizia Burra. The role of an integrated referral program for patients with liver disease: A network between hub and spoke centersUnited European Gastroenterology Journal 2024; 12(1): 76 doi: 10.1002/ueg2.12475
27
Elio C. Castro Filho, Juliana Piedade, Rodolfo Castro, Paula M. Luz, Flavia Fernandes, Beatriz Grinsztejn, Valdilea G. Veloso, Gustavo Henrique Pereira, Hugo Perazzo. Effectiveness of direct‐acting agents for chronic hepatitis C treatment in South America: A systematic review and meta‐analysisJournal of Viral Hepatitis 2020; 27(12): 1396 doi: 10.1111/jvh.13364
28
Sanket Mukherjee, Akhil Kumar, Jasmine Samal, Ekta Gupta, Perumal Vivekanandan, Manoj B. Menon. Selective Depletion of ZAP-Binding CpG Motifs in HCV EvolutionPathogens 2022; 12(1): 43 doi: 10.3390/pathogens12010043